PAF-antagonistic thienotriazolodiazepine compounds and pharmaceu

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

540560, 540568, C07D49512, C07D49504, A61K 3155

Patent

active

048207039

ABSTRACT:
A thienotriazolodiazepine compound of the formula: ##STR1## wherein A is alkylene or substituted alkylene and each other symbol is as defined in the specification and a pharmaceutically acceptable acid addition salt thereof, and pharmaceutical uses thereof.
Said compounds exhibit PAF-antagonistic activity and are useful for the prevention or treatment of various PAF-induced diseases.

REFERENCES:
patent: 3904641 (1975-09-01), Nakanishi
patent: 4155913 (1979-05-01), Hellerbach
patent: 4199588 (1980-04-01), Weber
patent: 4201712 (1980-05-01), Weber
Teresawa, Japanese Journal of Pharmacology, No. 4, vol. 44, pp. 381-391, Aug. 1987.
Yoshitomi Pharm. Co., Chemical Abstracts, vol. 94, p. 583, Abstract No. 47337w (1981).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

PAF-antagonistic thienotriazolodiazepine compounds and pharmaceu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with PAF-antagonistic thienotriazolodiazepine compounds and pharmaceu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PAF-antagonistic thienotriazolodiazepine compounds and pharmaceu will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-667394

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.